Jazz Pharmaceuticals plc’s recent filing unveils that its Chairman & CEO COZADD BRUCE C unloaded Company’s shares for reported $0.18 million on Feb 03 ’25. In the deal valued at $122.31 per share,1,500 shares were sold. As a result of this transaction, COZADD BRUCE C now holds 439,744 shares worth roughly $61.42 million.
Then, COZADD BRUCE C bought 1,500 shares, generating $183,465 in total proceeds.
Before that, COZADD BRUCE C sold 1,500 shares. Jazz Pharmaceuticals plc shares valued at $185,145 were divested by the Chairman & CEO at a price of $123.43 per share. As a result of the transaction, COZADD BRUCE C now holds 425,525 shares, worth roughly $59.43 million.
Wells Fargo upgraded its Jazz Pharmaceuticals plc [JAZZ] rating to an Overweight from a an Equal weight in a research note published on February 13, 2025; the price target was increased to $170 from $130. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who increased its forecast for the stock in mid December from “an Equal-weight” to “an Overweight”. Goldman began covering JAZZ with “Buy” recommendation on June 05, 2024. Robert W. Baird started covering the stock on January 03, 2024. It rated JAZZ as “an Outperform”.
Price Performance Review of JAZZ
On Tuesday, Jazz Pharmaceuticals plc [NASDAQ:JAZZ] saw its stock jump 2.18% to $139.67. Over the last five days, the stock has gained 3.16%. Jazz Pharmaceuticals plc shares have risen nearly 13.41% since the year began. Nevertheless, the stocks have risen 8.73% over the past one year. While a 52-week high of $138.27 was reached on 02/25/25, a 52-week low of $99.06 was recorded on 01/10/25. SMA at 50 days reached $125.27, while 200 days put it at $115.02.
Levels Of Support And Resistance For JAZZ Stock
The 24-hour chart illustrates a support level at 137.69, which if violated will result in even more drops to 135.72. On the upside, there is a resistance level at 141.08. A further resistance level may holdings at 142.50. The Relative Strength Index (RSI) on the 14-day chart is 73.28, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 5.96, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 3.97%. Stochastics %K at 91.99% indicates the stock is a selling.
